The dental technology developer’s proposed listing on the New York Stock Exchange would mark an exit for Henry Crown and Company.

The Ariad Pharmaceuticals-backed cancer therapeutics developer floated at the top of its range following $120m in venture funding.

Amdocs and Comcast contributed to deep learning software provider Neural Magic's $30m series A round while packaging producer Creapaper completed a series B featuring Ranpak.

The Bloomberg Beta-backed quantum chipmaker is joining forces with the publicly listed Supernova Partners Acquisition Company II.

Data collaboration software producer Duality Technologies, e-commerce logistics provider Pandion and cybersecurity software developer Adaptive Shield each raised $30m.

The cancer drug developer has closed an initial public offering which took place alongside a $160m SoftBank-led private placement.

The Benesse and Prosus-backed online learning platform operator has filed to list on Nasdaq, about a year after closing a series F round at a $3.25bn valuation.

Canon, Kansai Electric Power, Mitsui Fudosan, NEC, NTT Docomo, So-net and T-Gaia were among the investors that scored exits as the CCTV system provider went public.

SoftBank’s SB Opportunity Fund took part in international staffing services provider Ontop's $20m series A round while Emtek bcame digital payment processor Nium's latest corporate shareholder.

The immuno-oncology drug developer’s prospective initial public offering would mark exits for Takeda, Merck Group, Ipsen and Merck & Co.